Skip to content

The influence of individual parenteral nutrition in oncology – two-year Non-Interventional study in patients suffering from oncological disease and with individual parenteral nutrition (STIPEO)

The influence of individual parenteral nutrition in oncology – two-year Non-Interventional study in patients suffering from oncological disease and with individual parenteral nutrition (STIPEO) - NIS STIPEO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00010688
Enrollment
500
Registered
2016-07-05
Start date
2016-12-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

individual parenteral nutrition C00-C97 E40-E46 K93.8

Interventions

Group 1: Within the scope of non-interventional study STIPEO should be investigated how would be changed the nutritional condition under therapy with individual compounded parenteral (through direct a

Sponsors

ALPHAMADE GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - signed patient consent form - age = 18 years - oncological disease - indication for individual parenteral nutrition

Exclusion criteria

Exclusion criteria: - known hypersensitivity against agents and excipients or other ingredients of a parenteral nutrition

Design outcomes

Primary

MeasureTime frame
- Observation of the benefits of an individual parenteral nutrition in patients during or after chemotherapy regarding weight gain and nutritional condition. For the assessment of nutrition it will be used the MUST-scale. - Observation of the quality of life of patients with individual parenteral nutrition and treated with chemotherapy or patients who receive no chemotherapy. This is carried out on the basis of FACT-G-questionnaire (version 4, german).

Secondary

MeasureTime frame
- the safety profile of individual parenteral nutrition It is done by detecting (serious) adverse events and (serious) adverse events with suspected relationship for parenteral nutrition in accordance with Common Toxicity Criteria for Adverse Events (CTCAE, v.4.03). - analysis of the indication of individual parenteral nutrition on the basis of Subjective Global Assessments (SGA) - the conformity of the indication for individual parenteral nutrition with the guidelines of DGEM (the German Academy for Nutritional Medicine)

Countries

Germany

Contacts

Public ContactAnna Merk

ONKODATAMED

anna.merk@onkodatamed.de033424268910

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026